Literature DB >> 22528980

Dissolution techniques for in vitro testing of dry powders for inhalation.

Sabine May1, Birte Jensen, Markus Wolkenhauer, Marc Schneider, Claus Michael Lehr.   

Abstract

PURPOSE: To evaluate different dissolution testing methods and subsequently develop a simple to perform but reproducible and discriminating dissolution technique for inhalative powders.
METHODS: From a dry powder a fraction of aerosolized particles with an aerodynamic particle size below 5 μm was collected on regenerated cellulose membranes using an abbreviated Andersen cascade impactor. The membrane was then transferred to the respective dissolution set up either paddle apparatus with membrane holder, flow through cell or Franz diffusion cell.
RESULTS: All tested dissolution techniques could discriminate between good and poorly soluble substances, but only the paddle apparatus differentiated between small variations of solubility. We showed that membrane coverage and particle diameter play an important role for the dissolution rate. The profiles were fitted with mathematical models (e.g., Weibull, first order) choosing the best fit for determination of the mean dissolution time. Furthermore, a correlation between the dissolution profiles obtained with Franz cell compared to paddle apparatus could be shown.
CONCLUSION: The paddle apparatus with membrane holder has the best discrimination power with optimal reproducibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528980     DOI: 10.1007/s11095-012-0744-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Use of a novel modified TSI for the evaluation of controlled-release aerosol formulations. I.

Authors:  J T McConville; N Patel; N Ditchburn; M J Tobyn; J N Staniforth; P Woodcock
Journal:  Drug Dev Ind Pharm       Date:  2000-11       Impact factor: 3.225

2.  QSAR model for drug human oral bioavailability.

Authors:  F Yoshida; J G Topliss
Journal:  J Med Chem       Date:  2000-06-29       Impact factor: 7.446

3.  Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique.

Authors:  Michael Bur; Hanno Huwer; Leon Muys; Claus-Michael Lehr
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-06       Impact factor: 2.849

4.  Development of a standardized dissolution test method for inhaled pharmaceutical formulations.

Authors:  Yoen-Ju Son; Jason T McConville
Journal:  Int J Pharm       Date:  2009-08-07       Impact factor: 5.875

Review 5.  Pulmonary drug delivery: medicines for inhalation.

Authors:  Andreas Henning; Stephanie Hein; Marc Schneider; Michael Bur; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2010

6.  A novel method for assessing dissolution of aerosol inhaler products.

Authors:  Neal M Davies; Majid R Feddah
Journal:  Int J Pharm       Date:  2003-04-14       Impact factor: 5.875

7.  Nasal retention of budesonide and fluticasone in man: formation of airway mucosal budesonide-esters in vivo.

Authors:  H Petersen; A Kullberg; S Edsbäcker; L Greiff
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

8.  Solid lipid microparticles as a sustained release system for pulmonary drug delivery.

Authors:  Séverine Jaspart; Pascal Bertholet; Géraldine Piel; Jean-Michel Dogné; Luc Delattre; Brigitte Evrard
Journal:  Eur J Pharm Biopharm       Date:  2006-07-20       Impact factor: 5.571

9.  Percutaneous absorption on the relevance of in vitro data.

Authors:  T J Franz
Journal:  J Invest Dermatol       Date:  1975-03       Impact factor: 8.551

10.  Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols.

Authors:  Rania O Salama; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Eur J Pharm Biopharm       Date:  2008-04-22       Impact factor: 5.571

View more
  16 in total

1.  Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.

Authors:  Sharad Mangal; Rongkun Xu; Heejun Park; Dmitry Zemlyanov; Nivedita Shetty; Yu-Wei Lin; David Morton; Hak-Kim Chan; Jian Li; Qi Tony Zhou
Journal:  Pharm Res       Date:  2018-11-07       Impact factor: 4.200

Review 2.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

3.  Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.

Authors:  Sabine May; Birte Jensen; Claudius Weiler; Markus Wolkenhauer; Marc Schneider; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2014-05-23       Impact factor: 4.200

4.  Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.

Authors:  Sharad Mangal; Jiayang Huang; Nivedita Shetty; Heejun Park; Yu-Wei Lin; Heidi H Yu; Dmitry Zemlyanov; Tony Velkov; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-02-21       Impact factor: 5.875

Review 5.  iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System.

Authors:  Jayne E Hastedt; Per Bäckman; Antonio Cabal; Andy Clark; Carsten Ehrhardt; Ben Forbes; Anthony J Hickey; Guenther Hochhaus; Wenlei Jiang; Stavros Kassinos; Philip J Kuehl; David Prime; Yoen-Ju Son; Simon Teague; Ulrika Tehler; Jennifer Wylie
Journal:  Mol Pharm       Date:  2022-05-16       Impact factor: 5.364

6.  Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.

Authors:  Wenbo Wang; Qi Tony Zhou; Si-Ping Sun; John A Denman; Thomas R Gengenbach; Nicolas Barraud; Scott A Rice; Jian Li; Mingshi Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2015-11-24       Impact factor: 4.009

7.  Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.

Authors:  Chune Zhu; Jianting Chen; Shihui Yu; Chailu Que; Lynne S Taylor; Wen Tan; Chuanbin Wu; Qi Tony Zhou
Journal:  Mol Pharm       Date:  2020-07-24       Impact factor: 4.939

8.  Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.

Authors:  Eleonore Fröhlich
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.

Authors:  Hyo-Jung Lee; Ji-Hyun Kang; Hong-Goo Lee; Dong-Wook Kim; Yun-Seok Rhee; Ju-Young Kim; Eun-Seok Park; Chun-Woong Park
Journal:  Drug Des Devel Ther       Date:  2016-12-13       Impact factor: 4.162

10.  The CULTEX RFS: a comprehensive technical approach for the in vitro exposure of airway epithelial cells to the particulate matter at the air-liquid interface.

Authors:  Michaela Aufderheide; Beat Halter; Niklas Möhle; Dieter Hochrainer
Journal:  Biomed Res Int       Date:  2013-02-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.